Leading commercial air purification manufacturer, Fellowes, is pleased to announce its AeraMax Pro air purifiers have shown a 99.99% airborne reduction of a coronavirus surrogate within 60 minutes of operation.
With the recent, intensified focus on the reduction of airborne transmission of viruses, a number of worldwide bodies including the Centers for Disease Control and Prevention (CDC), ASHRAE, as well as ‘healthy building’ scientific advocates, have recommended that portable air cleaners using HEPA filtration can help in the protection against SARS-Cov-2.
In response to this, air purification expert, Fellowes recently arranged for its AeraMax Pro purifier, which has a four-stage TRUE HEPA filtration system, to be independently tested for efficacy in the reduction of two of the most health-threatening airborne-transmitted contaminants seen in recent times – coronavirus and the H1N1 virus.
Certified by Shanghai WEIPU Chemical Technology Service Company, Fellowes AeraMax Pro air purifiers demonstrated effectiveness in reducing the aerosolised airborne concentration of Human Coronavirus 229E in a test chamber, reaching 99.99% airborne reduction within one hour of operation. As it is not yet possible, or ethically responsible to aerosolise Sars-CoV-2 for airborne testing in the current climate, the coronavirus 229E was used as a surrogate to Sars-CoV-2.
Furthermore, AeraMax Pro air purifiers have also been proven to remove 99.9% of the H1N1 virus within 35 minutes of operation, as certified by Airmid Health Group Limited in Dublin, Ireland.
Darryl Brunt, Country Head – UK & Ireland at Fellowes Brands said: “With hygiene and health so high on the nation’s agenda, many will be seeking solutions that can help reduce the risk of the spread of infection, so that the public can safely return to, and go about their daily lives, whether it be in the workplace, leisure space or in education and healthcare establishments.
“I’m delighted that the results of these tests offer the reassurance that Fellowes AeraMax Pro air purifiers are indeed effective in removing forms of coronavirus from indoor air.”
Dr. Rajiv Sahay, Director of Environmental Diagnostics Laboratory at Pure Air Control Services based in Clearwater, Florida commented: “These latest test results on the Fellowes AeraMax Pro air purifiers provided by an independent third-party accredited (ISO/IEC 17025) laboratory are significant. I continue to be impressed with the findings on the efficacy of this technology/device by Fellowes. Typically, single-strand RNA envelope viruses (e.g. common cold coronavirus 229E, etc.) are used as a surrogate for SARS-CoV-2 to study the antiviral effect of a specific device.”
For over a decade, Fellowes AeraMax air purifiers have been a leading choice for localised air purification. Fellowes is the only solution that combines True HEPA filtration with EnviroSmart™ and PureView™ Technologies. EnviroSmart utilises multiple sensors to monitor contaminants and room occupancy continuously and adjusts automatically to provide maximum protection – on demand. PureView makes the invisible, visible with real-time screen updates on air quality and machine performance. This immediate feedback instils peace of mind for room occupants.
Fellowes Brands Global CEO, John Fellowes concluded: “Our company is proud to be of service to many businesses, schools, professional arenas and stadiums, and the fragile healthcare population’s reopening stories. While we’ve been providing health and wellness solutions to workplaces for years, our air purification business is among our most meaningful commitments to workplace health ever in our history.”
For more information about Fellowes AeraMax Pro air purifiers, CLICK HERE